New Jersey Economic Development Authority Fellowship Village Inc.; Long Term Care Jan 13

  • ID: 2384331
  • January 2013
  • Region: New Jersey
  • Standard & Poors


  • New Jersey Econ Dev Auth
  • MORE

Standard & Poor's Ratings Services affirmed its 'BBB+' rating, with a stable outlook, on New Jersey Economic Development Authority's series 2008 private-placement refunding bonds, issued for Fellowship Village Inc. The rating reflects our opinion of Fellowship Village's solid record of strong operating profitability, robust days' cash on hand, and strong occupancy. While many of Fellowships' financial metrics are in line with a higher rating, we believe these metrics are somewhat offset by an unrestricted-cash-to-long-term-debt ratio and, what we consider, high adjusted leverage. While these metrics have improved over the past few years, we recognize they are not yet strong enough to merit a rating change. In addition, Fellowship's plans to issue additional debt over the next several years will limit...

Companies mentioned in this report are:
- New Jersey Econ Dev Auth

Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

Note: Product cover images may vary from those shown

- New Jersey Econ Dev Auth

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.